Connection

CRISTY KU to Humans

This is a "connection" page, showing publications CRISTY KU has written about Humans.
Connection Strength

0.187
  1. Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector. Transl Vis Sci Technol. 2024 Jun 03; 13(6):11.
    View in: PubMed
    Score: 0.025
  2. Improved Rod Sensitivity as Assessed by Two-Color Dark-Adapted Perimetry in Patients With RPE65-Related Retinopathy Treated With Voretigene Neparvovec-rzyl. Transl Vis Sci Technol. 2023 04 03; 12(4):17.
    View in: PubMed
    Score: 0.023
  3. Stargardt Disease: Gene Therapy Strategies for ABCA4. Int Ophthalmol Clin. 2021 10 01; 61(4):157-165.
    View in: PubMed
    Score: 0.021
  4. The new landscape of retinal gene therapy. Am J Med Genet C Semin Med Genet. 2020 09; 184(3):846-859.
    View in: PubMed
    Score: 0.019
  5. Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration. JAMA Ophthalmol. 2017 07 01; 135(7):749-760.
    View in: PubMed
    Score: 0.015
  6. Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia. Ophthalmic Genet. 2016 12; 37(4):404-414.
    View in: PubMed
    Score: 0.014
  7. Gene Therapy Trial Update: A Primer for Vitreoretinal Specialists. Ophthalmic Surg Lasers Imaging Retina. 2016 Jan; 47(1):6-12.
    View in: PubMed
    Score: 0.014
  8. Viral-mediated vision rescue of a novel AIPL1 cone-rod dystrophy model. Hum Mol Genet. 2015 Feb 01; 24(3):670-84.
    View in: PubMed
    Score: 0.013
  9. Expanding the phenotypic and genotypic spectrum of patients with HGSNAT-related retinopathy. Ophthalmic Genet. 2024 Apr; 45(2):167-174.
    View in: PubMed
    Score: 0.006
  10. A possible ocular biomarker for response to hyperornithinemia in gyrate atrophy: the effect of pyridoxine, lysine, and arginine-restricted diet in a patient with advanced disease. Ophthalmic Genet. 2023 04; 44(2):191-197.
    View in: PubMed
    Score: 0.005
  11. Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5. Am J Ophthalmol. 2022 08; 240:285-301.
    View in: PubMed
    Score: 0.005
  12. Inherited Retinal Disease Panels-Caveat Emptor-Truly Know Your Inherited Retinal Disease Panel. Retina. 2022 01 01; 42(1):1-3.
    View in: PubMed
    Score: 0.005
  13. Effect of Pharmacological Pupil Dilation on Dark-Adapted Perimetric Sensitivity in Healthy Subjects Using an Octopus 900 Perimeter. Transl Vis Sci Technol. 2021 12 01; 10(14):18.
    View in: PubMed
    Score: 0.005
  14. Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome. Ophthalmic Genet. 2021 12; 42(6):664-673.
    View in: PubMed
    Score: 0.005
  15. Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome. Invest Ophthalmol Vis Sci. 2021 06 01; 62(7):27.
    View in: PubMed
    Score: 0.005
  16. Specific Alleles of CLN7/MFSD8, a Protein That Localizes to Photoreceptor Synaptic Terminals, Cause a Spectrum of Nonsyndromic Retinal Dystrophy. Invest Ophthalmol Vis Sci. 2017 06 01; 58(7):2906-2914.
    View in: PubMed
    Score: 0.004
  17. Molecular and Clinical Findings in Patients With Knobloch Syndrome. JAMA Ophthalmol. 2016 07 01; 134(7):753-62.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.